Mahzi Therapeutics
PrivateLast Round
Grant
Mar 27, 2026
Total Funding Raised
$47.79M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Mahzi Therapeutics is a biotechnology company that develops precision therapies for rare genetic neurodevelopmental disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Mahzi Therapeutics Comparables
Compare Mahzi Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Neurogene | 79% | |
| iNFixion Bioscience | 77% | |
| Capsida Biotherapeutics | 77% |
Mahzi Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Mar 27, 2026 | ||||
| Grant | Jan 30, 2025 | ||||
| Grant | Jun 27, 2024 | ||||
| Grant | Nov 29, 2022 | ||||
| Early Funding | Oct 7, 2021 | ||||
Seed | Dec 1, 2020 |
Key People
Founding team and executive leadership
Mahzi Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Droia Ventures | Early Funding |
| HealthCap | Early Funding |
| ArrowMark Partners | Early Funding |
| HBM Healthcare Investments | Early Funding |
| California Institute for Regenerative Medicine | Grant |
| Venrock | Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 27, 2026
$8M grant from California Institute for Regenerative Medicine.
Mahzi Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Mahzi Therapeutics's valuation, stock price, and market status.
Is Mahzi a public or private company?
Mahzi is a private company.
What is the current stock price of Mahzi?
Mahzi is a private company with no public stock price. No recent secondary market data is available.
How much is Mahzi worth (valuation)?
Valuation information for Mahzi is not publicly available.
Can I buy Mahzi stock?
Mahzi shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Mahzi's last funding round?
Mahzi's most recent funding round was Grant on January 30, 2025.
Who are the main investors in Mahzi?
Key investors in Mahzi include California Institute for Regenerative Medicine.
Will Mahzi IPO soon?
No public IPO plans have been announced for Mahzi.
How can I track Mahzi secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Mahzi's secondary market activity and sign up for updates.